This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. climbed 12.1% to $2.13 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.0% to 19,649.95 and the Dow Jones Industrial Average falling 0.5% to 44,368.56.
The stock's rise snapped a four-day losing streak.
Inovio Pharmaceuticals Inc. closed 85.6% below its 52-week high of $14.75, which the company achieved on April 1st.
The stock outperformed some of its competitors, as Johnson & Johnson fell 0.6% to $155.26, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.24% to $25.47.
Trading volume totaled 900,046, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 12, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。